Related Articles
Assessment of basal-like breast cancer by circulating tumor DNA analysis
Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report
Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma